Importantly, activation of the Hh signaling pathway, besides depending on canonical signaling (via Smo), can also be achieved through non-canonical activation (via the RAS/RAF pathway) in colon cancers (Varnat et al., 2009; Cai et al., 2015; Wu et al., 2017). Here, SMO is linked to malignant colon neoplasm.